Genetically modified T cells to target glioblastoma

Genetically modified T cells to target glioblastoma

Despite advances in surgical procedures, radiation- and chemotherapy the outcome for patients with glioblastoma (GBM) remains poor. While GBM cells express antigens that are potentially recognized by T cells, GBMs prevent the induction of GBM-specific immune responses by creating an immunosuppressiv...

Full description

Bibliographic Details
Main Authors: Simone eKrebs, Tania G Rodríguez-Cruz, Christopher eDeRenzo, Stephen eGottschalk
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-12-01
Series:Frontiers in Oncology
Subjects:
Glioblastoma
T cells
GBM
gene transfer
genetically modified T cells
antigen-specific T cells
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00322/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00322/full

Similar Items